Jump to content

Jeremy Farrar

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 09:05, 13 November 2016 (Journal cites, added 1 PMC, completed 1 page range using AWB (12100)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jeremy Farrar
Jeremy Farrar in 2009, portrait via wellcomeimges.org at the Wellcome Trust
Born
Jeremy James Farrar

(1961-09-01) 1 September 1961 (age 63)[13]
Singapore
Alma mater
Awards
Scientific career
Fields
Institutions
ThesisAnalysis of combinatorial immunoglobin libraries from a myasthenia gravis patient (1997)
Doctoral students
  • Jane Chun[8]
  • Abhilasha Karkey[9]
  • Vianney Tricou[10]
Website

Jeremy James Farrar (born 1961)[13] OBE, FRCP, FRS, FMedSci[1] was a Professor of Tropical medicine at the University of Oxford. In 2013, he was appointed director of the Wellcome Trust, one of world’s largest and wealthiest research charities.[13][7][15][16][17][18][19][20][21]

Education

Farrar was educated at University College London Medical School,[11] from where he obtained a Bachelor of Science degree in Immunology in 1983 and a Bachelor of Medicine, Bachelor of Surgery in 1986.[14] Farrar completed his Doctor of Philosophy degree at the University of Oxford in 1998 on myasthenia gravis.[22]

Career

From 1996 until 2013, Farrar was Director of the Oxford University Clinical Research Unit in Vietnam.[5][23][24][25][26] Farrar was Professor of Tropical Medicine and Global Health at the University of Oxford from 2000 until 2013.[13] In 2013, Farrar was appointed Director of the Wellcome Trust.[13]

Research

Farrar's research interests are in infectious diseases[11] such as Tuberculosis,[27] Dengue,[28][29][30][31] Typhoid fever, Malaria, and Influenza H5N1.[4][32][33][34][35]

Awards and honours

Farrar is a member of the Royal College of Physicians (MRCP) and the Academy of Medical Sciences (FMedSci) and an Officer of the Most Excellent Order of the British Empire (OBE). His citation on election to the Academy of Medical Sciences reads:

Jeremy Farrar is director of the Wellcome Trust-funded Oxford University Clinical Research Unit. Over the past ten years he has created a remarkable research institute in which his own research productivity has been phenomenal and an impressive training program has been developed. Under his direction the research programme has conducted seminal work on malaria, dengue, typhoid, tetanus, pyogenic and tuberculous meningitis and has become the leading centre for clinical research on avian influenza. These Pivotal clinical and virological studies have identified the dual importance of viral burden and the cytokine response to the lethal pathogenesis of avian influenza, and have described the rapid emergence of resistance to neuraminidase inhibitors. The unit has also conducted important research into Dengue shock syndrome, conducting the only large prospective randomised trials of fluid replacement and has provided an evidence-base for revision of the World Health Organisation classification. His commitment to fighting emerging infectious diseases at their source in developing countries is commendable and his contribution to capacity building in Vietnam and other countries is vital for the future of health care in these regions and serves as a model for others to follow.[3]

Farrar was elected a Fellow of the Royal Society (FRS) in 2015.[1]

References

  1. ^ a b c "Professor Jeremy Farrar OBE FMedSci FRS". London: Royal Society. Archived from the original on 2015-11-17.
  2. ^ a b Jeremy Farrar - Epidemiologist, BBC World Service
  3. ^ a b "Dr Jeremy Farrar OBE FMedSci". London: Academy of Medical Sciences. Archived from the original on 2014-09-25.
  4. ^ a b Woolhouse, Mark; Farrar, Jeremy (2014). "Policy: An intergovernmental panel on antimicrobial resistance". Nature. 509 (7502): 555–7. doi:10.1038/509555a. PMID 24877180.
  5. ^ a b http://www.oucru.org
  6. ^ The Farrar Foundation, farrarfoundation.org
  7. ^ a b Farrar, J; Cressey, D (2014). "Straight talk with...Jeremy Farrar". Nature Medicine. 20 (2): 112. doi:10.1038/nm0214-112. PMID 24504397.
  8. ^ Chun, Jane M (2014). Livelihoods under stress: household assets and responses to environmental change in the Mekong Delta, Vietnam (DPhil thesis). University of Oxford.
  9. ^ Karkey, Abhilasha (2012). Evaluation of strain circulation and the epidemiology of enteric fever caused (DPhil thesis). University of Oxford.
  10. ^ Tricou, Vianney M (2011). Dengue diagnostics and therapeutic interventions in Viet Nam (DPhil thesis). University of Oxford.
  11. ^ a b c Jeremy Farrar Interviewed by Jim Al-Khalili on The Life Scientific, 2014-07-14
  12. ^ Tickle, C; Crawley, A; Farrar, J (1989). "Retinoic acid application to chick wing buds leads to a dose-dependent reorganization of the apical ectodermal ridge that is mediated by the mesenchyme". Development (Cambridge, England). 106 (4): 691–705. PMID 2562664.
  13. ^ a b c d e FARRAR. "FARRAR, Dr Jeremy James". Who's Who. Vol. 2016 (online Oxford University Press ed.). Oxford: A & C Black. {{cite encyclopedia}}: Unknown parameter |othernames= ignored (help) (Subscription or UK public library membership required.) (subscription required)
  14. ^ a b Jeremy Farrar, BSc MBBS FRCP DPhil, antimicrobe.org
  15. ^ Van Noorden, Richard (2013). "Clinician to head Wellcome Trust: Jeremy Farrar to lead one of world's largest research charities". Nature. 497 (7447): 19. doi:10.1038/497019a.
  16. ^ Maxmen, A. (2009). "Jeremy Farrar: When disaster strikes". Journal of Experimental Medicine. 206 (1): 4–5. doi:10.1084/jem.2061pi. PMC 2626674. PMID 19153250.
  17. ^ Jeremy Farrar's publications indexed by the Scopus bibliographic database. (subscription required)
  18. ^ A very Wellcome appointment: Professor Jeremy Farrar, who takes over as director of the Wellcome Trust in October 2013, The Guaridan, 2013-04-25
  19. ^ Jeremy Farrar on Twitter
  20. ^ Pouplin, T.; Phuong, P. N.; Toi, P. V.; Nguyen Pouplin, J.; Farrar, J. (2014). "Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets". PLoS ONE. 9 (7): e102047. Bibcode:2014PLoSO...9j2047P. doi:10.1371/journal.pone.0102047. PMC 4086978. PMID 25004128.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  21. ^ Gilbert, M.; Golding, N.; Zhou, H.; Wint, G. R. W.; Robinson, T. P.; Tatem, A. J.; Lai, S.; Zhou, S.; Jiang, H.; Guo, D.; Huang, Z.; Messina, J. P.; Xiao, X.; Linard, C.; Van Boeckel, T. P.; Martin, V.; Bhatt, S.; Gething, P. W.; Farrar, J. J.; Hay, S. I.; Yu, H. (2014). "Predicting the risk of avian influenza a H7N9 infection in live-poultry markets across Asia". Nature Communications. 5. doi:10.1038/ncomms5116.
  22. ^ Farrar, Jeremy (1997). Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient (DPhil thesis). University of Oxford.
  23. ^ Watts, Geoff (2013). "Jeremy Farrar: Wellcome arrival from southeast Asia". The Lancet. 382 (9899): 1167. doi:10.1016/S0140-6736(13)62047-4.
  24. ^ Jeremy Farrar on Connecting your research with society on YouTube
  25. ^ Exchanges at the Frontier: Jeremy Farrar on YouTube
  26. ^ Jeremy Farrar seeks innovative backgrounds to help fight infectious diseases, Wired UK on YouTube
  27. ^ Thwaites, G. E.; Nguyen, N. D.; Nguyen, N. H.; Hoang, H. T.; Do, D. T. T.; Nguyen, N. T. C.; Nguyen, N. Q.; Nguyen, N. T.; Nguyen, N. N.; Nguyen, N. T. N.; Nguyen, N. N.; Nguyen, N. H.; Vu, V. N.; Cao, C. H.; Tran, T. T. H.; Pham, P. P.; Nguyen, N. T.; Stepniewska, K.; White, N. J.; Tran, T. T.; Farrar, J. J. (2004). "Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults". New England Journal of Medicine. 351 (17): 1741–1751. doi:10.1056/NEJMoa040573. PMID 15496623.
  28. ^ Tricou, V.; Vu, H. T.; Quynh, N. V.; Nguyen, C. V.; Tran, H. T.; Farrar, J.; Wills, B.; Simmons, C. P. (2010). "Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses". BMC Infectious Diseases. 10: 142. doi:10.1186/1471-2334-10-142. PMC 2895602. PMID 20509940.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  29. ^ Guzman, M. G.; Halstead, S. B.; Artsob, H.; Buchy, P.; Farrar, J.; Gubler, D. J.; Hunsperger, E.; Kroeger, A.; Margolis, H. S.; Martínez, E.; Nathan, M. B.; Pelegrino, J. L.; Simmons, C.; Yoksan, S.; Peeling, R. W. (2010). "Dengue: A continuing global threat". Nature Reviews Microbiology. 8 (12): S7–16. doi:10.1038/nrmicro2460. PMID 21079655.
  30. ^ Wills, B. A.; Dung, N. M.; Loan, H. T.; Tam, D. T. H.; Thuy, T. T. N.; Minh, L. T. T.; Diet, T. V.; Hao, N. T.; Chau, N. V.; Stepniewska, K.; White, N. J.; Farrar, J. J. (2005). "Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome". New England Journal of Medicine. 353 (9): 877–89. doi:10.1056/NEJMoa044057. PMID 16135832.
  31. ^ Solomon, T.; Dung, N. M.; Vaughn, D. W.; Kneen, R.; Thao, L. T. T.; Raengsakulrach, B.; Loan, H. T.; Day, N. P.; Farrar, J.; Myint, K. S.; Warrell, M. J.; James, W. S.; Nisalak, A.; White, N. J. (2000). "Neurological manifestations of dengue infection". The Lancet. 355 (9209): 1053–1059. doi:10.1016/S0140-6736(00)02036-5. PMID 10744091.
  32. ^ Farrar, J. (2012). "H5N1 surveillance: Shift expertise to where it matters". Nature. 483 (7391): 534–535. doi:10.1038/483534a. PMID 22460881.
  33. ^ Hien, T. T.; Nguyen, N. T.; Nguyen, N. T.; Luong, L. T.; Pham, P. P.; Nguyen, N. V. V.; Pham, P. T.; Vo, V. C.; Le, L. T. Q.; Ngo, N. T.; Dao, D. B.; Le, L. P.; Nguyen, N. T.; Hoang, H. T.; Cao, C. V.; Le, L. T.; Nguyen, N. D.; Le, L. H.; Nguyen, N. T. K.; Le, L. H.; Le, L. V.; Christiane, C.; Tran, T. T.; Menno De, M.; Schultsz, C.; Cheng, P.; Lim, W.; Horby, P.; Farrar, J.; World Health Organization International Avian Influenza Investigative Team (2004). "Avian Influenza A (H5N1) in 10 Patients in Vietnam". New England Journal of Medicine. 350 (12): 1179–1188. doi:10.1056/NEJMoa040419. PMID 14985470.
  34. ^ Jeremy Farrar publications indexed by Microsoft Academic
  35. ^ De Jong, M. D.; Simmons, C. P.; Thanh, T. T.; Hien, V. M.; Smith, G. J. D.; Chau, T. N. B.; Hoang, D. M.; Chau, N.; Khanh, T. H.; Dong, V. C.; Qui, P. T.; Cam, B.; Ha Do, D. Q.; Guan, Y.; Peiris, J. S. M.; Chinh, N. T.; Hien, T. T.; Farrar, J. (2006). "Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia". Nature Medicine. 12 (10): 1203–1207. doi:10.1038/nm1477. PMID 16964257.
Cultural offices
Preceded by Director of the Wellcome Trust
2013 – date 		Incumbent
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jeremy_Farrar&oldid=749252612"